Ernexa Therapeutics Inc. (ERNA) Asset Utilization Ratio (2011 - 2024)
Ernexa Therapeutics' (ERNA) quarterly Asset Utilization Ratio came in at 0.09 in Q4 2024, up 4583.76% YoY from 0.0 in Q1 2024, and up 297.5% on a QoQ basis from 0.02 in Q3 2024.
Ernexa Therapeutics Inc. (ERNA) Asset Utilization Ratio (2011 - 2024) Analysis & Trends
Ernexa Therapeutics (ERNA) has 13 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q4 2024.
- Quarterly Asset Utilization Ratio rose 4583.76% year-over-year to 0.09 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 0.09 (up 4583.76% YoY) and the FY2024 annual result came in at 0.02, up 687.61% from the prior year.
- Asset Utilization Ratio grew to 0.09 in Q4 2024, from 0.02 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.38 in Q1 2020 to a low of 0.0 in Q3 2023.
- A 4-year average of 0.28 and a median of 0.06 in 2023 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio plunged 99.51% — and 2024, when it surged 4583.76%.
- Tracing ERNA's Asset Utilization Ratio over 4 years: stood at 1.14 in 2020, then plunged by 89.21% to 0.12 in 2022, then slumped by 98.39% to 0.0 in 2023, then soared by 4583.76% to 0.09 in 2024.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q4 2024), 0.02 (Q3 2024), and 0.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.06 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.21 |
| Dec 31, 2020 | 1.14 |
| Mar 31, 2020 | 1.38 |
| Dec 31, 2019 | 1.36 |
| Sep 30, 2019 | 1.35 |
| Jun 30, 2019 | 1.37 |
| Mar 31, 2019 | 1.43 |
| Jun 30, 2018 | 1.37 |
| Mar 31, 2018 | 1.35 |
| Dec 31, 2017 | 1.25 |
| Sep 30, 2017 | 1.22 |
| Jun 30, 2017 | 1.23 |